RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol

      한글로보기

      https://www.riss.kr/link?id=A105094712

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-speci...

      27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation.
      Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors.
      Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol.

      더보기

      참고문헌 (Reference)

      1 Umetani M, "The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha" 20 : 172-182, 2014

      2 Willimann K, "The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7" 28 : 2025-2034, 1998

      3 Vurusaner B, "Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation" 77 : 376-385, 2014

      4 Piao M, "Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta : an immunohistological study" 13 : 82-89, 2006

      5 van de Laar L, "Regulation of dendritic cell development by GM-CSF : molecular control and implications for immune homeostasis and therapy" 119 : 3383-3393, 2012

      6 So T, "Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules" 4 : 139-, 2013

      7 Son Y, "Oxysterols induce transition of monocytic cells to phenotypically mature dendritic cell-like cells" 438 : 161-168, 2013

      8 Brown AJ, "Oxysterols and atherosclerosis" 142 : 1-28, 1999

      9 Majmundar AJ, "O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling" 32 : 36-49, 2012

      10 Vurusaner B, "Nrf2 antioxidant defense is involved in survival signaling elicited by 27-hydroxycholesterol in human promonocytic cells" 91 : 93-104, 2016

      1 Umetani M, "The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha" 20 : 172-182, 2014

      2 Willimann K, "The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7" 28 : 2025-2034, 1998

      3 Vurusaner B, "Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation" 77 : 376-385, 2014

      4 Piao M, "Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta : an immunohistological study" 13 : 82-89, 2006

      5 van de Laar L, "Regulation of dendritic cell development by GM-CSF : molecular control and implications for immune homeostasis and therapy" 119 : 3383-3393, 2012

      6 So T, "Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules" 4 : 139-, 2013

      7 Son Y, "Oxysterols induce transition of monocytic cells to phenotypically mature dendritic cell-like cells" 438 : 161-168, 2013

      8 Brown AJ, "Oxysterols and atherosclerosis" 142 : 1-28, 1999

      9 Majmundar AJ, "O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling" 32 : 36-49, 2012

      10 Vurusaner B, "Nrf2 antioxidant defense is involved in survival signaling elicited by 27-hydroxycholesterol in human promonocytic cells" 91 : 93-104, 2016

      11 Alvarez D, "Mechanisms and consequences of dendritic cell migration" 29 : 325-342, 2008

      12 Banchereau J, "Immunobiology of dendritic cells" 18 : 767-811, 2000

      13 Lee NY, "Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis" 23 : 2412-2423, 2012

      14 Chapuis F, "Differentiation of human dendritic cells from monocytes in vitro" 27 : 431-441, 1997

      15 Palucka KA, "Dendritic cells as the terminal stage of monocyte differentiation" 160 : 4587-4595, 1998

      16 Bobryshev YV, "Dendritic cells and their role in atherogenesis" 90 : 970-984, 2010

      17 Luther SA, "Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse" 97 : 12694-12699, 2000

      18 Ma L, "Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K) / AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer" 289 : 6921-6933, 2014

      19 Olofsson PS, "CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice" 117 : 1292-1301, 2008

      20 Berliner JA, "Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics" 91 : 2488-2496, 1995

      21 서현철, "7a-Hydroxycholesterol Elicits TLR6-Mediated Expression of IL-23 in Monocytic Cells" 한국응용약물학회 23 (23): 84-89, 2015

      22 Kim SM, "27-Hydroxycholesterol up-regulates CD14 and predisposes monocytic cells to superproduction of CCL2 in response to lipopolysaccharide" 1852 : 442-450, 2015

      23 Wu Q, "27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth" 5 : 637-645, 2013

      24 Kim SM, "27-Hydroxycholesterol induces recruitment of monocytic cells by enhancing CCL2 production" 442 : 159-164, 2013

      25 Kim SM, "27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1lymphocytes" 274 : 462-470, 2014

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-04-29 학술지명변경 외국어명 : THE KOREAN JOURNAL OF Physiology & Pharmacology -> The Korean Journal of Physiology & Pharmacology KCI등재
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-10-12 학술지명변경 한글명 : 대한 생리.약리학회지 -> The Korean Journal of Physiology & Pharmacology
      외국어명 : THE KOREAN JOURNAL OF Physilogy & Pharmacology -> THE KOREAN JOURNAL OF Physiology & Pharmacology
      KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.85 0.36 1.29
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.05 0.9 0.575 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼